12:00 AM
 | 
Apr 28, 2003
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Gilead Sciences Inc.

(GILD), Foster City, Calif.

Business: Infectious diseases

Pacific Growth Equities analyst Tomas Dietz increased his 2003 EPS and Viread sales estimates. He now expects GILD to earn $0.80, up...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >